Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Fibroblast
AddedFeb 15, 2024
UpdatedJun 18, 2026
Fibroblast

Fibroblast

Fibroblast provides a cloud-based tool for patient self-scheduling and instant referrals.

HQ
Chicago, IL, US
Founded
2010
Overview
Compare
Fundraising
Employees

Fibroblast offers a cloud-based practice management tool that

facilitates online patient self-scheduling and instant cross-referrals.

Fibroblast - Similar Companies

Doctible logo

Doctible

doctible.com

Fetch MD logo

Fetch MD

NexHealth logo

NexHealth

nexhealth.com

Fibo logo

Fibo

Ezdoctor logo

Ezdoctor

OrthoFi logo

OrthoFi

orthofi.com

flipMD logo

flipMD

TeleMedicX logo

TeleMedicX

telemedicx.com

Treatspace logo

Treatspace

treatspace.com

Phreesia logo

Phreesia

phreesia.com

Opathica logo

Opathica

Prospyr Medical logo

Prospyr Medical

prospyrmed.com

BookThatDoc.com logo

BookThatDoc.com

HealerPlus logo

HealerPlus

healerplus.com

GetDoctor logo

GetDoctor

getdoctor.co

Fibroblast - Quick Facts

Who are Fibroblast's competitors?

Companies similar to Fibroblast include Doctible, Fetch MD, NexHealth and Fibo.

When was Fibroblast founded?

Fibroblast was founded in 2010.

Where is Fibroblast's headquarters located?

Fibroblast's headquarters is located in Chicago, IL, US.

When was Fibroblast's last funding round?

Fibroblast's most recent funding round was for $2M (USD) in January 2018.

How much has Fibroblast raised to-date?

As of Jan 15, 2018, Fibroblast has raised a total of $2.9M (USD).

How many employees does Fibroblast have?

Fibroblast has 30 employees as of Feb 5, 2024.

Fibroblast - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Cloud
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Small Business
Main Product
  • Practice Management
  • Referrals
Tags
  • Healthtech
  • SaaS
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7372Prepackaged Software
Show 5 more industry codes
NAICS
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified